Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-01-05 @ 11:07 PM
Study NCT ID:
NCT00641056
Status:
COMPLETED
Last Update Posted:
2015-06-15
First Post:
2008-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2009-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-17
First Submit QC Date:
None
Study First Post Date:
2008-03-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-02-14
Results First Submit QC Date:
None
Results First Post Date:
2012-07-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-08-18
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-05-21
Last Update Post Date:
2015-06-15
Last Update Post Date Type:
ESTIMATED